Gianopulos K, Makio A, Pritchard S, Cunha C, Hull M, Nicola A
Viruses. 2024; 16(2).
PMID: 38400027
PMC: 10892784.
DOI: 10.3390/v16020251.
Xie M
Results Probl Cell Differ. 2023; 71:283-318.
PMID: 37996683
DOI: 10.1007/978-3-031-37936-9_14.
Ruan P, Wang M, Cheng A, Zhao X, Yang Q, Wu Y
Front Microbiol. 2023; 14:1268429.
PMID: 37808279
PMC: 10559885.
DOI: 10.3389/fmicb.2023.1268429.
Pataki Z, Sanders E, Heldwein E
PLoS Pathog. 2022; 18(6):e1010435.
PMID: 35767585
PMC: 9275723.
DOI: 10.1371/journal.ppat.1010435.
Zhu Q, Zhao G, Li Y, Talakatta G, Mai H, Le Q
MedComm (2020). 2021; 2(2):175-206.
PMID: 34766141
PMC: 8491203.
DOI: 10.1002/mco2.32.
Potent anti-tumor effects of receptor-retargeted syncytial oncolytic herpes simplex virus.
Suzuki T, Uchida H, Shibata T, Sasaki Y, Ikeda H, Hamada-Uematsu M
Mol Ther Oncolytics. 2021; 22:265-276.
PMID: 34553018
PMC: 8426171.
DOI: 10.1016/j.omto.2021.08.002.
Herpes simplex virus 2 (HSV-2) evolves faster in cell culture than HSV-1 by generating greater genetic diversity.
Lopez-Munoz A, Rastrojo A, Martin R, Alcami A
PLoS Pathog. 2021; 17(8):e1009541.
PMID: 34437654
PMC: 8389525.
DOI: 10.1371/journal.ppat.1009541.
Combination of long- and short-read sequencing fully resolves complex repeats of herpes simplex virus 2 strain MS complete genome.
Lopez-Munoz A, Rastrojo A, Kropp K, Viejo-Borbolla A, Alcami A
Microb Genom. 2021; 7(6).
PMID: 34170814
PMC: 8461477.
DOI: 10.1099/mgen.0.000586.
Virus-Mediated Cell-Cell Fusion.
Leroy H, Han M, Woottum M, Bracq L, Bouchet J, Xie M
Int J Mol Sci. 2020; 21(24).
PMID: 33348900
PMC: 7767094.
DOI: 10.3390/ijms21249644.
evolution of herpes simplex virus 1 (HSV-1) reveals selection for syncytia and other minor variants in cell culture.
Kuny C, Bowen C, Renner D, Johnston C, Szpara M
Virus Evol. 2020; 6(1):veaa013.
PMID: 32296542
PMC: 7151645.
DOI: 10.1093/ve/veaa013.
Intravenous Injections of a Rationally Selected Oncolytic Herpes Virus as a Potent Virotherapy for Hepatocellular Carcinoma.
Luo Y, Lin C, Ren W, Ju F, Xu Z, Liu H
Mol Ther Oncolytics. 2019; 15:153-165.
PMID: 31720372
PMC: 6838930.
DOI: 10.1016/j.omto.2019.09.004.
First Impressions-the Potential of Altering Initial Host-Virus Interactions for Rational Design of Herpesvirus Vaccine Vectors.
Rider P, Musarrat F, Nabil R, Naidu S, Kousoulas K
Curr Clin Microbiol Rep. 2018; 5(1):55-65.
PMID: 30560044
PMC: 6294296.
DOI: 10.1007/s40588-018-0082-1.
Structural basis for membrane anchoring and fusion regulation of the herpes simplex virus fusogen gB.
Cooper R, Georgieva E, Borbat P, Freed J, Heldwein E
Nat Struct Mol Biol. 2018; 25(5):416-424.
PMID: 29728654
PMC: 5942590.
DOI: 10.1038/s41594-018-0060-6.
Herpes simplex virus Membrane Fusion.
Weed D, Nicola A
Adv Anat Embryol Cell Biol. 2017; 223:29-47.
PMID: 28528438
PMC: 5869023.
DOI: 10.1007/978-3-319-53168-7_2.
Syncytial Mutations Do Not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus.
Okubo Y, Uchida H, Wakata A, Suzuki T, Shibata T, Ikeda H
J Virol. 2016; 90(24):11096-11105.
PMID: 27707922
PMC: 5126368.
DOI: 10.1128/JVI.01456-16.
Interplay between the Herpes Simplex Virus 1 gB Cytodomain and the gH Cytotail during Cell-Cell Fusion.
Rogalin H, Heldwein E
J Virol. 2015; 89(24):12262-72.
PMID: 26401042
PMC: 4665236.
DOI: 10.1128/JVI.02391-15.
Evidence for the Use of Multiple Mechanisms by Herpes Simplex Virus-1 R7020 to Inhibit Intimal Hyperplasia.
McCormick S, He Q, Stern J, Khodarev N, Weichselbaum R, Skelly C
PLoS One. 2015; 10(7):e0130264.
PMID: 26132411
PMC: 4488439.
DOI: 10.1371/journal.pone.0130264.
Using a split luciferase assay (SLA) to measure the kinetics of cell-cell fusion mediated by herpes simplex virus glycoproteins.
Saw W, Matsuda Z, Eisenberg R, Cohen G, Atanasiu D
Methods. 2015; 90:68-75.
PMID: 26022509
PMC: 4655157.
DOI: 10.1016/j.ymeth.2015.05.021.
Rapid genome assembly and comparison decode intrastrain variation in human alphaherpesviruses.
Parsons L, Tafuri Y, Shreve J, Bowen C, Shipley M, Enquist L
mBio. 2015; 6(2).
PMID: 25827418
PMC: 4453532.
DOI: 10.1128/mBio.02213-14.
Herpes simplex virus 1 gN partners with gM to modulate the viral fusion machinery.
El Kasmi I, Lippe R
J Virol. 2014; 89(4):2313-23.
PMID: 25505065
PMC: 4338903.
DOI: 10.1128/JVI.03041-14.